Instituto Oncológico de Andalucía,
La terapia de células T con receptor de antígeno quimérico (CAR-T) ha revolucionado el tratamiento de los cánceres hematológicos…
Second Primary Cancer After Chimeric Antigen Receptor–T-Cell Therapy
Overview of attention for article published in JAMA Oncology, February 2025
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (96th percentile)
-
Good Attention Score compared to outputs of the same age and source (67th percentile)
Readers on
- mendeley
- 15 Mendeley